5,342
Views
68
CrossRef citations to date
0
Altmetric
Research Articles

A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)

ORCID Icon &
Pages 4111-4121 | Received 10 May 2020, Accepted 20 May 2020, Published online: 11 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Soumen Barman, Snehasudha Subhadarsini Sahoo, Jyotirmayee Padhan & Babu Sudhamalla. (2023) Identification of novel natural product inhibitors of BRD4 using high throughput virtual screening and MD simulation. Journal of Biomolecular Structure and Dynamics 41:20, pages 10569-10581.
Read now
Moumita Nath & Pradip Debnath. (2023) Therapeutic role of traditionally used Indian medicinal plants and spices in combating COVID-19 pandemic situation. Journal of Biomolecular Structure and Dynamics 41:12, pages 5894-5913.
Read now
Karteek Rao Amperayani, Govinda Varadhi, Baswanth Oruganti & Uma Devi Parimi. (2023) Molecular dynamics and absolute binding free energy studies of piperine derivatives as potential inhibitors of SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Martiniano Bello. (2022) Elucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets. Journal of Biomolecular Structure and Dynamics 40:18, pages 8375-8383.
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2022) Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches. Journal of Biomolecular Structure and Dynamics 40:9, pages 4110-4121.
Read now
Faizul Azam, Ismail M. Taban, Eltayeb E. M. Eid, Muzaffar Iqbal, Ozair Alam, Shamshir Khan, Danish Mahmood, Md Jamir Anwar, Habibullah Khalilullah & M. U. Khan. (2022) An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin α. Journal of Biomolecular Structure and Dynamics 40:6, pages 2851-2864.
Read now
Mohammed Hakmi, E L Mehdi Bouricha, Jihane Akachar, Badreddine Lmimouni, Jaouad El Harti, Lahcen Belyamani & Azeddine Ibrahimi. (2022) In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2. Journal of Biomolecular Structure and Dynamics 40:4, pages 1546-1557.
Read now
Priyashi Rao, Arpit Shukla, Paritosh Parmar, Rakesh M. Rawal, Baldev V. Patel, Meenu Saraf & Dweipayan Goswami. (2022) Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics. Journal of Biomolecular Structure and Dynamics 40:1, pages 348-360.
Read now
Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Asheet Kumar Nath, Hemant Darbari & Rajendra Joshi. (2021) Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). Journal of Biomolecular Structure and Dynamics 39:15, pages 5735-5755.
Read now
Sk. Abdul Amin, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors. Journal of Biomolecular Structure and Dynamics 39:13, pages 4764-4773.
Read now
Durgesh Kumar, Kamlesh Kumari, Vijay Kumar Vishvakarma, Abhilash Jayaraj, Dhiraj Kumar, Venkatesh Kumar Ramappa, Rajan Patel, Vinod Kumar, Sujata K. Dass, Ramesh Chandra & Prashant Singh. (2021) Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:13, pages 4671-4685.
Read now
Debanjan Kundu & Vikash Kumar Dubey. (2021) Potential alternatives to current cholinesterase inhibitors: an in silico drug repurposing approach. Drug Development and Industrial Pharmacy 47:6, pages 919-930.
Read now
Abdullahi Temitope Jamiu, Carolina H. Pohl, Sharafa Bello, Toluwase Adedoja & Saheed Sabiu. (2021) A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets. All Life 14:1, pages 1100-1128.
Read now

Articles from other publishers (54)

Pradeep Kumar R.. (2024) Need and Possibilities of Phytocompounds against SARS-CoV-2: Recent Advances in COVID-19 Therapy. Current Traditional Medicine 10:1.
Crossref
HARITA DESAI, ADITYA MHATRE, RASHMI SINGH, GAURI LOKHANDE, ASHWINI KONDHARE & SAKSHI BUNDAKE. (2023) EXPLORING THE POTENTIAL OF HERBAL THERAPY IN COVID-19. International Journal of Current Pharmaceutical Research, pages 50-60.
Crossref
Jainey P. James, Divya Jyothi, Vinod Devaraji & Sneh Priya. (2023) In silico Exploration of Dakshina Kannada Medicinal Plants as Anti- SARS-CoV-2 Agents by Molecular Docking and Simulation Approaches. Letters in Drug Design & Discovery 20:10, pages 1544-1556.
Crossref
Sunday Amos Onikanni, Bashir Lawal, Valens Munyembaraga, Oluwafemi Shittu Bakare, Muhammad Taher, Junaidi Khotib, Deny Susanti, Babatunji Emmanuel Oyinloye, Lloyd Noriega, Ayodeji Famuti, Adewale Oluwaseun Fadaka & Basiru Olaitan Ajiboye. (2023) Profiling the Antidiabetic Potential of Compounds Identified from Fractionated Extracts of Entada africana toward Glucokinase Stimulation: Computational Insight. Molecules 28:15, pages 5752.
Crossref
Ishwarya Muralitharan, Ajaya Kumar Sahoo, Priya Dharshini Augusthian & Areejit Samal. (2023) Computational prediction of phytochemical inhibitors against the cap-binding domain of Rift Valley fever virus. Molecular Diversity.
Crossref
Bahaa A. Hemdan, Ahmed Mostafa, Marwa M. Elbatanony, Amal M. El-Feky, Tsvetelina Paunova-Krasteva, Stoyanka Stoitsova, Mohamed Azab El-Liethy, Gamila E. El-Taweel & Mobarak Abu Mraheil. (2023) Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities. PLOS ONE 18:3, pages e0282729.
Crossref
R.P. Vivek-Ananth, Karthikeyan Mohanraj, Ajaya Kumar Sahoo & Areejit Samal. (2023) IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants. ACS Omega 8:9, pages 8827-8845.
Crossref
Naveena Menpadi, Jay Prakash, Debanjan Kundu, Pranjal Chandra & Vikash Kumar Dubey. (2023) Integrated computational and experimental approach for novel anti-leishmanial molecules by targeting Dephospho-coenzyme A kinase. International Journal of Biological Macromolecules 232, pages 123441.
Crossref
Shilin Zhou, Panpan Lv, Mingxue Li, Zihui Chen, Hong Xin, Svetlana Reilly & Xuemei Zhang. (2023) SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomedicine & Pharmacotherapy 159, pages 114242.
Crossref
Virender Kumar, Yogesh Kumar, Rajat Huria, Suryadev Kumar, Tarun Kalson, Deepak Jangra, Davinder Kumar & Bharti Mangla. (2023) Herbal Medicines Used for the Management of COVID-19. Coronaviruses 4:1.
Crossref
Abdirahman Elmi, Ahmed Said Mohamed, Saredo Said & Remy Bationo. 2023. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products 549 573 .
Kathirvel Bharathi, Ajith Sivasangar Latha, Arumugam Jananisri, Venkataramanaravi Bavyataa, Boopalan Rajan, Balasubramanian Balamuralikrishnan, Mariadhas Valan Arasu, Naif Abdullah Al-Dhabi, Beulah Catharine & Arumugam Vijaya Anand. 2023. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products. Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products 447 478 .
Md Nasir Ahmed & Kerry Hughes. (2022) Role of ethno-phytomedicine knowledge in healthcare of COVID-19: advances in traditional phytomedicine perspective. Beni-Suef University Journal of Basic and Applied Sciences 11:1.
Crossref
Waseem Ahmad Ansari, Fahmina Rizvi, Mohsin Ali Khan, Zaw Ali Khan & Mohammad Faheem Khan. (2022) Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta indica (Indian Neem) Against Delta and Omicron Variants of SARS-CoV-2. Coronaviruses 3:5.
Crossref
Nishat Sultan, Mandeep Kaur & Amina Sultan. (2022) Potential role of herbal medicinal agents against COVID-19 infection. International Journal of Oral Health Dentistry 8:3, pages 209-215.
Crossref
Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi & Mohammad Hossein Asgarshamsi. (2022) The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects. Biophysical Chemistry 288, pages 106824.
Crossref
Abdurrahman Pharmacy Yusuf, Jian-ye Zhang, Jing-quan Li, Aliyu Muhammad & Murtala Bello Abubakar. (2022) Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges. Phytomedicine Plus 2:3, pages 100280.
Crossref
Isha Rani, Avjit Kalsi, Gagandeep Kaur, Pankaj Sharma, Sumeet Gupta, Rupesh K. Gautam, Hitesh Chopra, Shabana Bibi, Syed Umair Ahmad, Inderbir Singh, Manish Dhawan & Talha Bin Emran. (2022) Modern drug discovery applications for the identification of novel candidates for COVID-19 infections. Annals of Medicine and Surgery 80, pages 104125.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Bipasa Kar, Budheswar Dehury, Mahender Kumar Singh, Sanghamitra Pati & Debdutta Bhattacharya. (2022) Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study. Journal of Molecular Graphics and Modelling 114, pages 108192.
Crossref
Temidayo D. Popoola, Peter A. Segun, Edmund Ekuadzi, Rita A. Dickson, Olanrewaju R. Awotona, Lutfun Nahar, Satyajit D. Sarker & Amos A. Fatokun. (2022) West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19. DARU Journal of Pharmaceutical Sciences 30:1, pages 191-210.
Crossref
Marina R. Wylie & D. Scott Merrell. (2022) The Antimicrobial Potential of the Neem Tree Azadirachta indica. Frontiers in Pharmacology 13.
Crossref
Sundaresan Bhavaniramya, Vanajothi Ramar, Selvaraju Vishnupriya, Ramasamy Palaniappan, Ashokkumar Sibiya & Baskaralingam Vaseeharan. (2022) Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19. Current Molecular Pharmacology 15:2, pages 393-417.
Crossref
Monu Pande, Debanjan Kundu & Ragini Srivastava. (2021) Vitamin C and Vitamin D3 show strong binding with the amyloidogenic region of G555F mutant of Fibrinogen A alpha-chain associated with renal amyloidosis: proposed possible therapeutic intervention. Molecular Diversity 26:2, pages 939-949.
Crossref
Nikhil Avinash Patil, Prakash Macchindra Gore, Dhivya Shanmugrajan, Harshal Patil, Mahesh Kudav & Balasubramanian Kandasubramanian. (2021) Functionalized non-woven surfaces for combating the spread of the COVID-19 pandemic. Interface Focus 12:1.
Crossref
Abhisek Jana, Tarun Roy, Sarbajit Layek, Subhas Ghosal & Deb Ranjan Banerjee. (2021) Computational Investigation on Natural Quinazoline Alkaloids as Potential Inhibitors of the Main Protease (Mpro) of SARS-CoV-2. Journal of Computational Biophysics and Chemistry 21:01, pages 65-82.
Crossref
Qiaoming Liu, Jun Wan & Guohua Wang. (2022) A survey on computational methods in discovering protein inhibitors of SARS-CoV-2. Briefings in Bioinformatics 23:1.
Crossref
Diky Setya Diningrat, Ayu Nirmala Sari, Novita Sari Harahap & Kusdianti. (2021) Potential of Hanjeli (Coix lacryma-jobi) essential oil in preventing SARS-CoV-2 infection via blocking the Angiotensin Converting Enzyme 2 (ACE2) receptor. Journal of Plant Biotechnology 48:4, pages 289-303.
Crossref
Abdallah S. Abdelsattar, Zahraa M. El-Awadly, Mai Abdelgawad, Fayrouz Mahmoud, Sahar A. Allam & Mohamed A. Helal. (2021) The Role of Molecular Modeling and Bioinformatics in Treating a Pandemic Disease: The Case of COVID-19. The Open COVID Journal 1:1, pages 216-234.
Crossref
Amit Lochab, Rakhi Thareja, Sangeeta D. Gadre & Reena Saxena. (2021) Potential Protein and Enzyme Targets for In‐silico Development and Repurposing of Drug Against Coronaviruses. ChemistrySelect 6:46, pages 13363-13381.
Crossref
Olutayo Ademola Adeleye, Mbang Nyong Femi-Oyewo, Oluyemisi Adebowale Bamiro, Lateef Gbenga Bakre, Akinyinka Alabi, Joseph Senu Ashidi, Olalekan Adeyinka Balogun-Agbaje, Oluwakemi Mary Hassan & Gbemisola Fakoya. (2021) Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Reza Farjaminezhad & Ghasemali Garoosi. (2021) Improvement and prediction of secondary metabolites production under yeast extract elicitation of Azadirachta indica cell suspension culture using response surface methodology. AMB Express 11:1.
Crossref
Dipak Khadka, Man Kumar Dhamala, Feifei Li, Prakash Chandra Aryal, Pappu Rana Magar, Sijar Bhatta, Manju Shree Thakur, Anup Basnet, Dafang Cui & Shi Shi. (2021) The use of medicinal plants to prevent COVID-19 in Nepal. Journal of Ethnobiology and Ethnomedicine 17:1.
Crossref
Tanmoy Dutta, Nabajyoti Baildya, Abdul Ashik Khan & Narendra Nath Ghosh. (2021) Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies. Network Modeling Analysis in Health Informatics and Bioinformatics 10:1.
Crossref
Jean-Louis Kraus. (2021) Natural Products as Potential Antiviral Drugs: The Specific Case of Marine Biotoxins. Russian Journal of Bioorganic Chemistry 47:6, pages 1127-1132.
Crossref
Khojasteh Malekmohammad & Mahmoud Rafieian-Kopaei. (2021) Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Current Pharmaceutical Design 27:38, pages 3996-4007.
Crossref
Lakhnarayan Kumar Bhagarathi, Ms. Ferial Pestano, Mrs. Zenesia Phillips-Henry, Ms. Chalasa Cossiah, Mr. Phillip N. B. DaSilva & Mr. Dharamdeo Singh. (2021) A Review on the Properties of Azadirachta indica, Ocimum tenuiflorum and Cymbopogon citratus. International Journal of Scientific Research and Management 9:10, pages 96-164.
Crossref
CHANDRASEKAR R, SIVAGAMI B & SATHEESH KUMAR G. (2021) POTENTIAL PHYTOCONSTITUENTS FROM NATURAL PRODUCTS FOR COMBATING AGAINST CORONAVIRUS DISEASE-19 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS‐2) - A REVIEW. Asian Journal of Pharmaceutical and Clinical Research, pages 8-18.
Crossref
Varinder Singh, Meghaditya Roy, Nidhi Garg, Amit Kumar, Sandeep Arora & Deepinder Singh Malik. (2021) An Insight into the Dermatological Applications of Neem: A Review on Traditional and Modern Aspect. Recent Advances in Anti-Infective Drug Discovery 16:2, pages 94-121.
Crossref
Majid Hassanzadeganroudsari, Amir Ahmadi, Niloufar Rashidi, Md Hossain, Amanda Habib & Vasso Apostolopoulos. (2021) Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 1:2, pages 111-128.
Crossref
Nikhil Avinash Patil, Prakash Macchindra Gore, Niranjana Jaya Prakash, Premika Govindaraj, Ramdayal Yadav, Vivek Verma, Dhivya Shanmugarajan, Shivanand Patil, Abhay Kore & Balasubramanian Kandasubramanian. (2021) Needleless electrospun phytochemicals encapsulated nanofibre based 3-ply biodegradable mask for combating COVID-19 pandemic. Chemical Engineering Journal 416, pages 129152.
Crossref
J. Adithya, Bhagyalakshmi Nair, T.S. Aishwarya & Lekshmi R. Nath. (2021) The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review. Current Pharmaceutical Biotechnology 22:7, pages 906-919.
Crossref
K.Abraham Peele, Vikas Kumar, Shraddha Parate, Krupanidhi Srirama, Keun Woo Lee & T.C. Venkateswarulu. (2021) Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2. Journal of Pharmaceutical Sciences 110:6, pages 2346-2354.
Crossref
Yipeng Cao, Rui Yang, Imshik Lee, Wenwen Zhang, Jiana Sun, Wei Wang & Xiangfei Meng. (2021) Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors . Protein Science 30:6, pages 1114-1130.
Crossref
Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim & Md. Sahab Uddin. (2021) Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Frontiers in Pharmacology 12.
Crossref
Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, Bilyaminu Abubakar, Muhammad Bashir Bello, Aliyu Muhammad, Siew Hua Gan, Aliyu Ibrahim Dabai, M Alblihed, Arabinda Ghosh, Reem H. Badr, Devarajan Thangadurai & Mustapha Umar Imam. (2021) Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies. Frontiers in Pharmacology 12.
Crossref
Namita Ashish Singh, Pradeep Kumar, Jyoti & Naresh Kumar. (2021) Spices and herbs: Potential antiviral preventives and immunity boosters during COVID ‐19 . Phytotherapy Research 35:5, pages 2745-2757.
Crossref
Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba & Chinedum Peace Babalola. (2021) Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective. Frontiers in Pharmacology 12.
Crossref
Xin Yi Lim, Bee Ping Teh & Terence Yew Chin Tan. (2021) Medicinal Plants in COVID-19: Potential and Limitations. Frontiers in Pharmacology 12.
Crossref
Arumugam Vijaya Anand, Balasubramanian Balamuralikrishnan, Mohandass Kaviya, Kathirvel Bharathi, Aluru Parithathvi, Meyyazhagan Arun, Nachiappan Senthilkumar, Shanmugam Velayuthaprabhu, Muthukrishnan Saradhadevi, Naif Abdullah Al-Dhabi, Mariadhas Valan Arasu, Mohammad Iqbal Yatoo, Ruchi Tiwari & Kuldeep Dhama. (2021) Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 26:6, pages 1775.
Crossref
Hardeep Singh Tuli, Shivani Sood, Jagjit Kaur, Pawan Kumar, Prachi Seth, Sandeep Punia, Priya Yadav, Anil Kumar Sharma, Diwakar Aggarwal & Katrin Sak. (2021) Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements. 3 Biotech 11:2.
Crossref
Neelu Batra, Cristabelle De Souza, Jyoti Batra, Alan G. Raetz & Ai-Ming Yu. (2020) The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). International Journal of Molecular Sciences 21:17, pages 6412.
Crossref
Farhana Rumzum Bhuiyan, Sabbir Howlader, Topu Raihan & Mahmudul Hasan. (2020) Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic. Frontiers in Medicine 7.
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses 329 431 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.